Lee Financial CO Catalent, Inc. Transaction History

Lee Financial CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$31.86 - $67.26 $5,894 - $12,443	-185 Reduced 52.86%	165 $7,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $2,044 - $3,341	45 Added 14.75%	350 $22,000
Q4 2022 Feb 09, 2023	BUY	$41.39 - $81.0 $4,966 - $9,720	120 Added 64.86%	305 $13,000
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $1,308 - $1,710	-15 Reduced 7.5%	185 $20,000
Q1 2022 May 11, 2022	SELL	$94.19 - $124.49 $1,883 - $2,489	-20 Reduced 9.09%	200 $22,000
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $597 - $695	-5 Reduced 2.22%	220 $28,000
Q2 2021 Aug 04, 2021	BUY	$100.34 - $115.69 $1,505 - $1,735	15 Added 7.14%	225 $24,000
Q3 2020 Nov 03, 2020	SELL	$72.74 - $92.5 $2,545 - $3,237	-35 Reduced 14.29%	210 $18,000
Q2 2020 Aug 11, 2020	SELL	$48.02 - $79.04 $3,361 - $5,532	-70 Reduced 22.22%	245 $18,000
Q1 2020 May 07, 2020	BUY	$36.95 - $62.95 $1,293 - $2,203	35 Added 12.5%	315 $16,000
Q3 2017 Nov 07, 2017	BUY	$33.75 - $41.67 $9,450 - $11,667	280	280 $11,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.